Literature DB >> 5259578

Clinical magnesium deficiency.

H E Martin.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1969        PMID: 5259578     DOI: 10.1111/j.1749-6632.1969.tb13018.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


× No keyword cloud information.
  10 in total

Review 1.  Minerals and osteoporosis.

Authors:  H Rico
Journal:  Osteoporos Int       Date:  1991-10       Impact factor: 4.507

2.  Magnesium supplementation in Bartter's syndrome.

Authors:  J W Mace; K M Hambidge; R W Gotlin; R S Dubois; C S Solomons; F H Katz
Journal:  Arch Dis Child       Date:  1973-06       Impact factor: 3.791

3.  Primary hypomagnesemia with secondary hypocalcemia, diarrhea and insensitivity to parathyroid hormone.

Authors:  J C Woodard; P D Webster; A A Carr
Journal:  Am J Dig Dis       Date:  1972-07

Review 4.  Low intracellular magnesium in patients with acute pancreatitis and hypocalcemia.

Authors:  E Ryzen; R K Rude
Journal:  West J Med       Date:  1990-02

Review 5.  [Hypo- and hypermagnesemia from the cardiologic viewpoint].

Authors:  K Lossnitzer
Journal:  Klin Wochenschr       Date:  1971-11-01

6.  Does parenteral magnesium sulfate have an antiemetic effect during chemotherapy with cis-platinum?

Authors:  P E Ballmer; W H Reinhart
Journal:  Cancer Chemother Pharmacol       Date:  1989       Impact factor: 3.333

7.  Renal magnesium wasting, incomplete tubular acidosis, hypercalciuria and nephrocalcinosis in siblings.

Authors:  F Manz; K Schärer; P Janka; J Lombeck
Journal:  Eur J Pediatr       Date:  1978-06-20       Impact factor: 3.183

8.  Low blood mononuclear cell magnesium content and hypocalcemia in normomagnesemic patients.

Authors:  E Ryzen; T A Nelson; R K Rude
Journal:  West J Med       Date:  1987-11

Review 9.  A clinical approach to common electrolyte problems: 4. Hypomagnesemia.

Authors:  C Berkelhammer; R A Bear
Journal:  Can Med Assoc J       Date:  1985-02-15       Impact factor: 8.262

10.  Prophylaxis against hypomagnesaemia induced by cis-platinum combination chemotherapy.

Authors:  V M Macaulay; R H Begent; M E Phillips; E S Newlands
Journal:  Cancer Chemother Pharmacol       Date:  1982       Impact factor: 3.333

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.